Sources | Names Used |
---|---|
GDSC1000 | KIN001-102 |
PharmacoGx | KIN001-102 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIP | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | HSPA5 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | MAP1LC3B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
mRNA | LYL1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | TAF15 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | DGAT1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | CEP95 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | MED1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | PARVB | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | LGALS9 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |